Literature DB >> 2931225

T gamma lymphocytosis is clinically non-progressive but immunologically heterogeneous.

F Miedema, F G Terpstra, J W Smit, J P van der Veen, C J Melief.   

Abstract

Immunological studies were performed with the expanded T gamma cells of five patients with T gamma lymphocytosis. All patients showed a stable clinical picture with persistent T gamma lymphocytosis and neutropenia, with or without recurrent infections. The expanded T gamma cells in the blood had the T1-3+4-8+11+M1- phenotype, with the exception of one patient whose cells lacked the T8 marker. The expanded T gamma cell population did not proliferate in response to T cell mitogens and did not show immunoregulatory activity on pokeweed mitogen driven immunoglobulin synthesis. In four of the five patients the T gamma cells had killer cell activity against IgG sensitized mouse mastocytoma cells. Taken together, these results and the data from the literature, it is concluded that T gamma lymphocytosis represents a spectrum of T cell expansions clearly distinct from clinically progressive mature T cell neoplasias.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2931225      PMCID: PMC1577291     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity.

Authors:  F Pandolfi; D M Strong; R B Slease; M L Smith; J R Ortaldo; R B Herberman
Journal:  Blood       Date:  1980-10       Impact factor: 22.113

2.  Cooperative effects in mitogen- and antigen-induced responses of human peripheral blood lymphocyte subpopulations.

Authors:  M H van Oers; J Pinkster; W P Zeijlemaker
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

3.  A morphologic and immunologic study of the large granular lymphocyte in neutropenia with T lymphocytosis.

Authors:  W C Chan; I Check; C Schick; R K Brynes; J Kateley; E F Winton
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

4.  Regulatory activity of neoplastic T cells in Sezary syndrome on in vitro immunoglobulin production.

Authors:  F Miedema; R Willemze; F G Terpstra; W A van Vloten; C J Meijer; C J Melief
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

5.  HNK-1 monoclonal antibody (Leu-7) in the identification of abnormal expansions of large granular lymphocytes.

Authors:  F Pandolfi; G Semenzato; G de Rossi; I Quinti; C Guglielmi; A Pezzutto; M Lopez; G Tonietti; L Fontana; T Abo; F Aiuti
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

6.  Proliferation of T gamma cells with killer-cell activity in two patients with neutropenia and recurrent infections.

Authors:  A A Bom-van Noorloos; H G Pegels; R H van Oers; J Silberbusch; T M Feltkamp-Vroom; R Goudsmit; W P Zeijlemaker; A E von dem Borne; C J Melief
Journal:  N Engl J Med       Date:  1980-04-24       Impact factor: 91.245

7.  T8 chronic lymphocytic leukemia. A distinctive disorder related to T8 lymphocytosis.

Authors:  J U Brisbane; L D Berman; M E Osband; R S Neiman
Journal:  Am J Clin Pathol       Date:  1983-09       Impact factor: 2.493

8.  Natural killer and suppressor T-cell chronic lymphocytic leukemia.

Authors:  M Palutke; L Eisenberg; J Kaplan; M Hussain; K Kithier; P Tabaczka; I Mirchandani; D Tenenbaum
Journal:  Blood       Date:  1983-09       Impact factor: 22.113

9.  A case of chronic lymphocytic leukemia with properties characteristic of natural killer cells.

Authors:  K Itoh; K Tsuchikawa; T Awataguchi; K Shiiba; K Kumagai
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

10.  Functional properties of neoplastic T cells in adult T cell lymphoma/leukemia patients from the Caribbean.

Authors:  F Miedema; F G Terpstra; J W Smit; S Daenen; W Gerrits; U Hegde; E Matutes; D Catovsky; M F Greaves; C J Melief
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

View more
  2 in total

1.  Analysis of helper activity on pokeweed mitogen- and interleukin 2-driven immunoglobulin synthesis by neoplastic T4+ cells.

Authors:  F Miedema; J W van Oostveen; F G Terpstra; A W van den Wall Bake; R Willemze; E A Rauws; R Bieger; M B van 't Veer; D Catovsky; C J Melief
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  Granular lymphocyte proliferative disorders: a multicenter study of 20 cases.

Authors:  S Woessner; E Feliu; N Villamor; M A Zarco; A Domingo; F Millá; L Florensa; M Rozman; E Abella; J Soler
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.